Cargando…

Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data

Purpose: To describe drug-use patterns in patients with multiple sclerosis (MS) using disease-modifying drugs (DMDs) and to estimate the incidence of severe adverse events (SAEs) of treatment. Methods: We conducted a cohort study within the German Pharmacoepidemiological Research Database between Ja...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simbrich, Alexandra, Thibaut, Jasmine, Khil, Laura, Berger, Klaus, Riedel, Oliver, Schmedt, Niklas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549763/ https://www.ncbi.nlm.nih.gov/pubmed/31213818 http://dx.doi.org/10.2147/NDT.S200930

Ejemplares similares

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
por: Simbrich, Alexandra, et al.
Publicado: (2020)

Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims Data
por: Scholle, Oliver, et al.
Publicado: (2021)

Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database
por: Huang, Liping, et al.
Publicado: (2020)

Frequency and trends of disease‐modifying antirheumatic drug (DMARD) use in Germany
por: Fassmer, Alexander M., et al.
Publicado: (2016)

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data
por: Ohlmeier, Christoph, et al.
Publicado: (2020)

Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study
por: Ohlmeier, Christoph, et al.
Publicado: (2015)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023)

Database of adverse events associated with drugs and drug combinations
por: Poleksic, Aleksandar, et al.
Publicado: (2019)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs
por: Munsell, Michael, et al.
Publicado: (2017)

Development of an adverse drug event network to predict drug toxicity
por: Wu, Qier, et al.
Publicado: (2020)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
por: Brown, Joshua D.
Publicado: (2020)

Administrative Claims Analysis of the Relationship Between Warfarin Use and Risk of Hemorrhage Including Drug-Drug and Drug-Disease Interactions
por: Zhang, Kui, et al.
Publicado: (2006)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
por: Budikayanti, Astri, et al.
Publicado: (2018)

Adverse drug events in the critical care unit
por: Seynaeve, S, et al.
Publicado: (2010)

Standardizing adverse drug event reporting data
por: Wang, Liwei, et al.
Publicado: (2014)

Exploring adverse drug events at the class level
por: Winnenburg, Rainer, et al.
Publicado: (2015)

Adverse Event Circumstances and the Case of Drug Interactions
por: Soldatos, Theodoros G., et al.
Publicado: (2019)

Preventable adverse drug events: Descriptive epidemiology
por: Woo, Stephanie A., et al.
Publicado: (2020)

Preventing Medication Errors and Adverse Drug Events
por: Curtiss, Frederic R.
Publicado: (2003)

Adverse Drug Events in the Elderly: An Ongoing Problem
por: Gray, Charnelda, et al.
Publicado: (2009)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Katsuno, Hayato, et al.
Publicado: (2021)

Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study
por: Ayani, Nobutaka, et al.
Publicado: (2022)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Pneumococcal vaccination rates in immunocompromised patients—A cohort study based on claims data from more than 200,000 patients in Germany
por: Schmedt, Niklas, et al.
Publicado: (2019)

German translation and validation of the Reporting of Clinical Adverse Events Scale (RoCAES-D)
por: Litke, Nicola Alexandra, et al.
Publicado: (2020)

Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
por: Roitmann, Eva, et al.
Publicado: (2014)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database
por: Fried, Linda, et al.
Publicado: (2022)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use
por: Rushovich, Tamara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dlo5mbkq9eohmlf3f2edfdm8vs